Table 4 Clinical features of imported microscopic malaria and SMM
Clinical features by group | |||
|---|---|---|---|
Microscopic malaria | Submicroscopic malaria | p value | |
Time to diagnosis (days) | 11 (0-730) | 12 (0-1544) | 0.276 (M) |
Symptomatic | 168 (88.9%) | 30 (28.8%) | < 0.001 |
Liver enlargement | 17 (9%) | 11 (10.6%) | 0.0659 |
Spleen enlargement | 29 (15.3%) | 14 (13.5%) | 0.663 |
Asthenia | 153 (91.1%) | 22 (73.3%) | 0.011 (F) |
Headache | 119 (70.8%) | 12 (40%) | 0.001 |
Ocular pain | 39 (23.2%) | 3 (10%) | 0.103 |
Arthromyalgia | 116 (69%) | 16 (53.3%) | 0.093 |
Vomiting | 36 (21.4%) | 2 (6.7%) | 0.059 |
Diarrhoea | 37 (22%) | 2 (6.7%) | 0.051 |
Rash | 1 (0.6%) | 1 (3.3%) | 0.281 (F) |
Cough | 4 (2.4%) | 2 (6.7%) | 0.226 (F) |
Abdominal pain | 5 (3%) | 2 (6.7%) | 0.287 |
Fever | 160 (95.2%) | 18 (60%) | < 0.001 (F) |
Tropical splenomegaly | 3 (1.8%) | 4 (13.3%) | 0.011 (F) |
Severe malaria | 13 (6.9%) | 0 (0%) | 0.005 (F) |